CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Grant or award Chief Marketing Officer acquired 9,865 shares (grant or award)
- 4 Grant or award EVP&Pres, Merck Animal Heallth acquired 12,264 shares (grant or award)
- 4 Grant or award Chairman, CEO & President acquired 47,434 shares (grant or award)
- 4 Grant or award Exe V-P & Pres. MMD acquired 13,880 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Comm. & Public Afrs Ofcr sold 7,085 shares at $87.00 ($616,395)
- 4 Open-market sale EVP,Chief Info&Digital Officer sold 8,614 shares at $83.59 ($720,040)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion EVP,Chief Info&Digital Officer acquired 17,119 shares (option exercise)
- 4 Exercise or conversion Chief Marketing Officer acquired 36,903 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 99 · 1,973 filings